Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2025-01-13 shademei 来自山西省

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受

2 0

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-12-23 ms1000000382468845 来自重庆

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2025-01-09 ms8000000124135786

多久才能pubmed检索啊

4 0

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-01-01 ms4000001668897773 来自北京

偏重的研究方向：肿瘤
经验分享：23.12.27 submit 24.1.1 仍然initial validation

101 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-12-28 shademei

偏重的研究方向：肿瘤
经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-12-19 1469407fm39暂无昵称来自石川县

审稿速度:24.0 | 投稿命中率:50.0
经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。

9 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-10-25 ms1000001788822128 来自北京

editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。

64 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-12-10 ms3000001788822132 来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：实践综述，个人觉得审稿速度挺快的。
一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。
后面就是漫长的返修等待，最后在前天录用了
我是9月底投稿的总共耗时2个多月。

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2024-08-07 ms3000001758728711 来自河南省

各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭

251 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2247822, encodeId=79ad224e82258, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：审稿周期太长了，将近11个月，胃癌蛋白组学的分层模型，刚开始邀请2个审稿人，结果有一个给了provoke,再次邀请花费了将近3个月，最后1 1月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Mon Jan 13 01:43:01 CST 2025, time=2025-01-13, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2244569, encodeId=2523224456950, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：我也是从投稿到现在已经4个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，还让我自己找编辑。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01bd6152710, createdName=ms1000000382468845, createdTime=Mon Dec 23 22:32:31 CST 2024, time=2024-12-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2247280, encodeId=86c0224e2800b, content=多久才能pubmed检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b65452622, createdName=ms8000000124135786, createdTime=Thu Jan 09 14:13:27 CST 2025, time=2025-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2245292, encodeId=ecd32245292ea, content=偏重的研究方向：肿瘤 经验分享：胃癌的预后模型，发表周期比较长，11个月，中间有一个审稿人给了provoke,耽误了三个月，重新找的审稿人，但是回复意见要详尽, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Sat Dec 28 09:14:21 CST 2024, time=2024-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2243444, encodeId=8ee1224344404, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：从投稿到现在已经3个月，还没有给分配编辑，发邮件回复说没有找到合适的编辑，这都是借口。该期刊不知道遇到了什么困境，建议慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ca1e5149909, createdName=1469407fm39暂无昵称, createdTime=Thu Dec 19 09:27:09 CST 2024, time=2024-12-19, status=1, ipAttribution=石川县), GetPortalCommentsPageByObjectIdResponse(id=2233197, encodeId=bad0223319e3f, content=editorial assignment一个月了，还没分配编辑，有邮件催了，但是还是每动静，比较担心，太墨迹人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:59:43 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241751, encodeId=c5a62241e5145, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实践综述，个人觉得审稿速度挺快的。 一审1个月左右就完成，我总共邀请了两位审稿人，两位都给了修改意见。 后面就是漫长的返修等待，最后在前天录用了 我是9月底投稿的总共耗时2个多月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms3000001788822132, createdTime=Tue Dec 10 23:22:15 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2218917, encodeId=3b21221891eac, content=各位老师，一个审稿人endorsed了，但是另一个审稿人没消息，状态是We are awaiting a response from Reviewer 2 in the interactive forum.求问是什么情况啊😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48bf9338681, createdName=ms3000001758728711, createdTime=Wed Aug 07 11:37:37 CST 2024, time=2024-08-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2125738, encodeId=fe1f2125e3890, content=纯SEER数据库还能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=77465191005, createdName=14718874m55(暂无昵称), createdTime=Thu Apr 13 20:11:41 CST 2023, time=2023-04-13, status=1, ipAttribution=辽宁省)]

2023-04-13 14718874m55(暂无昵称) 来自辽宁省

纯SEER数据库还能投吗

96 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务